Healthcare | September 22, 2021
MetroMedi ties up with BMS Fit Club for diabetes management
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
It becomes the first ophthalmology biosimilar to gain FDA approval in the United States
Clindamycin Phosphate Foam, 1% is the generic version of Evoclin Foam, 1%
RxDx is a chain of primary care driven multispecialty healthcare clinics with two main branches situated in Whitefield and Malleswaram in Bengaluru
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced breast cancer in the first-line (1L) setting
The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
Eka Care will provide a six-month complimentary trial period to all members who register before December 31, 2021
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
Subscribe To Our Newsletter & Stay Updated
